Zenas BioPharma, Inc.
ZBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $342,223 | $688,558 | $688,558 |
| - Cash | $319,742 | $56,857 | $67,209 |
| + Debt | $1,003 | $21,113 | $1,527 |
| Enterprise Value | $23,484 | $652,814 | $622,876 |
| Revenue | $5,000 | $50,000 | $0 |
| % Growth | -90% | – | – |
| Gross Profit | -$134,139 | $50,000 | -$61,689 |
| % Margin | -2,682.8% | 100% | – |
| EBITDA | -$163,751 | -$27,034 | -$75,121 |
| % Margin | -3,275% | -54.1% | – |
| Net Income | -$156,988 | -$37,124 | -$119,282 |
| % Margin | -3,139.8% | -74.2% | – |
| EPS Diluted | -3.76 | -0.97 | -3.11 |
| % Growth | -287.6% | 68.8% | – |
| Operating Cash Flow | -$119,674 | -$30,529 | -$65,652 |
| Capital Expenditures | -$131 | -$17 | -$2,198 |
| Free Cash Flow | -$119,805 | -$30,546 | -$67,850 |